About this Journal Submit a Manuscript Table of Contents
PPAR Research
Volume 2012 (2012), Article ID 929052, 9 pages
http://dx.doi.org/10.1155/2012/929052
Research Article

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells

1Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, USA
2Basic Science and Craniofacial Biology, New York University College of Dentistry, 345 East 24th Street, New York City, NY 10010, USA

Received 1 September 2011; Revised 22 November 2011; Accepted 23 November 2011

Academic Editor: R. P. Phipps

Copyright © 2012 Adrienne Bolden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Adrienne Bolden, Lynikka Bernard, Danielle Jones, Tunde Akinyeke, and LaMonica V. Stewart, “The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells,” PPAR Research, vol. 2012, Article ID 929052, 9 pages, 2012. doi:10.1155/2012/929052